FOLH1 and neoplasm: However, even if PSMA-617 has been reported to have slower tumor accumulation and clearance kinetics than PSMA-11 [35], a significant difference in the detection of HGG using different PSMA-targeting radiopharmaceuticals was not demonstrated.